Provided by Tiger Trade Technology Pte. Ltd.

CALCIMEDICA

2.30
-0.0270-1.16%
Volume:45.87K
Turnover:107.46K
Market Cap:15.67M
PE:-0.34
High:2.47
Open:2.30
Low:2.21
Close:2.32
52wk High:36.00
52wk Low:2.20
Shares:6.83M
Float Shares:3.96M
Volume Ratio:0.18
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6528
EPS(LYR):-9.8500
ROE:-365.70%
ROA:-63.58%
PB:2.84
PE(LYR):-0.23

Loading ...

NASDAQ Trade Halt Continues Halt News Pending at 08:59 Pm

Reuters
·
Aug 29

Calcimedica Inc trading halted, news pending

TIPRANKS
·
Aug 29

CalciMedica to effect 1-for-5 reverse stock split

TIPRANKS
·
Aug 27

CalciMedica Announces One-for-Five Reverse Stock Split

THOMSON REUTERS
·
Aug 27

CalciMedica Price Target Announced at $9.00/Share by Guggenheim

Dow Jones
·
Aug 20

CalciMedica Shareholders Approve 7.5 Million-Share Increase to Equity Incentive Plan

Reuters
·
Aug 20

CalciMedica initiated with a Buy at Guggenheim

TIPRANKS
·
Aug 20

Analysts Offer Insights on Healthcare Companies: NextCure (NXTC) and CalciMedica (CALC)

TIPRANKS
·
Aug 13

CalciMedica Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

CalciMedica Q2 EPS $(0.45) Misses $(0.28) Estimate

Benzinga Earnings
·
Aug 11

CalciMedica Q2 FY26 Net Loss Widens to $7.65 Million

Reuters
·
Aug 11

CalciMedica Q2 Basic EPS USD -0.45

THOMSON REUTERS
·
Aug 11

Press Release: CalciMedica Reports Second Quarter 2026 Financial Results and Provides Clinical & Corporate Updates

Dow Jones
·
Aug 11

CalciMedica Inc Expected to Post a Loss of 28 Cents a Share - Earnings Preview

Reuters
·
Aug 08

CalciMedica announces FDA alignment on Phase 2b Auxora trial design

TIPRANKS
·
Jul 29

CalciMedica, FDA alignment de-risks regulatory path, says H.C. Wainwright

TIPRANKS
·
Jul 29

CalciMedica Reaches FDA Alignment on Phase 2b Trial Design for Auxora in Acute Pancreatitis

MT Newswires Live
·
Jul 29

CalciMedica - Expects Ind Submission for Cm5480 in Mid-2027

THOMSON REUTERS
·
Jul 29

CalciMedica Announces FDA Alignment on Phase 2B Trial Design for Auxora in Acute Pancreatitis and Identifies Disease's First Potential Registrational Endpoints

THOMSON REUTERS
·
Jul 29

CalciMedica - Plans Phase 1B Trial for Auxora in Pah with Data Expected Mid-2027

THOMSON REUTERS
·
Jul 29